Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| SimoTech | PerkinElmer | Pharmaceuticals (NEC) | $36.0M – $48.8M | 9× – 12× | |
| GentleDrop | Mu Medical | Pharmaceuticals (NEC) | $15.3M – $20.7M | n/m | |
| Energon Labs | Cotecna | Pharmaceuticals (NEC) | $18.0M – $24.4M | 8× – 11× | |
| Syntegon Technology | Apollo Global Management | Pharmaceuticals (NEC) | $0.0M | 9× – 12× | |
| Life Sciences & Healthcare business of Clarivate | Altaris | Pharmaceuticals (NEC) | $3,103M – $4,198M | 12× – 16× | |
| Validation Systems Inc | FST Technical Services, Z2 | Pharmaceuticals (NEC) | $18.3M – $24.7M | 6× – 8× | |
| Lifecore Biomedical | Webster Equity Partners | Pharmaceuticals (NEC) | $664M | n/m | |
| Biorbyt | AVS Bio, Arlington Capital Partners | Pharmaceuticals (NEC) | $43.0M – $58.0M | 7× – 9× | |
| Dickson | Copeland | Pharmaceuticals (NEC) | $165M – $223M | 11× – 15× | |
| Purna Pharmaceuticals | Ampersand Capital Partners | Pharmaceuticals (NEC) | $86.7M – $117M | 10× – 14× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.